T1	CHEM 56 65	abatacept
#1	AnnotatorNotes T1	C1619966; abatacept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T2	PROC 99 112	diagnosticado
#2	AnnotatorNotes T2	C0011900; Diagnosis; Diagnostic Procedure
T3	DISO 127 146	artritis reumatoide
#3	AnnotatorNotes T3	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T4	PROC 170 211	Ensayo Fase 3B, aleatorizado, doble ciego
T5	PROC 217 248	evaluar la eficacia y seguridad
#4	AnnotatorNotes T5	C0511730; Identify product efficacy and safety issues; Health Care Activity
T6	CHEM 252 261	abatacept
#5	AnnotatorNotes T6	C1619966; abatacept; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T7	CHEM 284 295	metotrexato
#6	AnnotatorNotes T7	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T8	CHEM 310 321	metotrexato
#7	AnnotatorNotes T8	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T9	PROC 325 336	monoterapia
#8	AnnotatorNotes T9	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T10	PROC 1555 1577	fórmula Cockroft-Gault
#9	AnnotatorNotes T10	C4064204; renal creatinine clearance predicted by Cockroft-Gault formula; Laboratory Procedure
T11	DISO 387 406	artritis reumatoide
#10	AnnotatorNotes T11	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T12	PROC 420 431	tratamiento
#11	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	CHEM 443 454	metotrexato
#12	AnnotatorNotes T13	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T14	DISO 478 497	Artritis reumatoide
#13	AnnotatorNotes T14	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T15	DISO 548 550	AR
#14	AnnotatorNotes T15	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T16	PROC 575 586	diagnóstico
#15	AnnotatorNotes T16	C0011900; Diagnosis; Diagnostic Procedure
T17	DISO 659 661	AR
#16	AnnotatorNotes T17	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T18	PROC 785 788	VSG
#17	AnnotatorNotes T18	C1176468; Erythrocyte sedimentation rate measurement; Laboratory Procedure [Velocidad de sedimentación glomerular]
T19	DISO 833 857	articulaciones dolorosas
#18	AnnotatorNotes T19	C0003862; Arthralgia; Sign or Symptom
T20	DISO 871 896	articulaciones inflamadas
#19	AnnotatorNotes T20	C0003864; Arthritis; Disease or Syndrome
T21	PROC 907 917	Evaluación
#20	AnnotatorNotes T21	C1261322; Evaluation procedure; Health Care Activity
T22	ANAT 937 951	articulaciones
#21	AnnotatorNotes T22	C0022417; Joints; Body Space or Junction | C1269611; Entire joint; Body Space or Junction
T23	ANAT 1495 1503	cervical
T24	CHEM 1030 1067	anticuerpos anti-proteína citrulinada
#22	AnnotatorNotes T24	C4505301; Anti-Citrullinated Protein Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor
T25	CHEM 1069 1073	ACPA
T26	DISO 1151 1163	tuberculosis
#23	AnnotatorNotes T26	C0041296; Tuberculosis; Disease or Syndrome
T27	DISO 1179 1194	infección aguda
#24	AnnotatorNotes T27	C0275518; Acute infectious disease; Disease or Syndrome
T28	DISO 1235 1298	infecciones bacterianas, virales o fúngicas sistémicas crónicas
T29	DISO 1329 1348	neoplasias malignas
#25	AnnotatorNotes T29	C0006826; Malignant Neoplasms; Neoplastic Process
T30	ANAT 1454 1467	espinocelular
#26	AnnotatorNotes T30	C1181285; Prickle cell of epidermis; Cell
T31	ANAT 1470 1481	basocelular
#27	AnnotatorNotes T31	C0596155; Basal Cell; Cell
T32	DISO 1485 1511	carcinoma cervical in situ
#28	AnnotatorNotes T32	C0851140; Carcinoma in situ of uterine cervix; Neoplastic Process
T33	PROC 1515 1541	Aclaramiento de creatinina
#29	AnnotatorNotes T33	C0373595; Creatinine clearance measurement; Laboratory Procedure
T34	PROC 759 762	PCR
#30	AnnotatorNotes T34	C0201657; C-reactive protein measurement; Laboratory Procedure
T35	ANAT 833 847	articulaciones
#31	AnnotatorNotes T35	C0022417; Joints; Body Space or Junction | C1269611; Entire joint; Body Space or Junction
T36	ANAT 871 885	articulaciones
#32	AnnotatorNotes T36	C0022417; Joints; Body Space or Junction | C1269611; Entire joint; Body Space or Junction
T37	DISO 1429 1481	carcinoma no metastásico espinocelular o basocelular
T38	CHEM 1531 1541	creatinina
#33	AnnotatorNotes T38	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T39	Date 13 17	2015
T40	LIVB 69 78	pacientes
#34	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	Date 113 126	recientemente
T42	Route 262 264	SC
T43	LIVB 375 382	adultos
#35	AnnotatorNotes T43	C0001675; Adult; Age Group
T44	Neg_cue 416 419	sin
T45	LIVB 536 543	Sujetos
#36	AnnotatorNotes T45	C0681850; Study Subject; Group
T46	Date 626 630	2010
T47	Duration 665 684	los 6 meses previos
T48	LIVB 692 699	sujetos
#37	AnnotatorNotes T48	C0681850; Study Subject; Group
T51	LIVB 807 814	sujetos
#38	AnnotatorNotes T51	C0681850; Study Subject; Group
T52	Date 973 981	el Día 1
T53	LIVB 999 1006	Sujetos
#39	AnnotatorNotes T53	C0681850; Study Subject; Group
T54	LIVB 1078 1085	Sujetos
#40	AnnotatorNotes T54	C0681850; Study Subject; Group
T55	LIVB 1129 1136	Sujetos
#41	AnnotatorNotes T55	C0681850; Study Subject; Group
T56	Spec_cue 1141 1150	riesgo de
T57	LIVB 1167 1174	Sujetos
#42	AnnotatorNotes T57	C0681850; Study Subject; Group
T58	Date 1195 1203	reciente
T59	LIVB 1207 1214	Sujetos
#43	AnnotatorNotes T59	C0681850; Study Subject; Group
T60	LIVB 1260 1267	virales
#44	AnnotatorNotes T60	C0042776; Virus; Virus
T61	LIVB 1270 1278	fúngicas
#45	AnnotatorNotes T61	C0016832; Fungi; Fungus
T62	Duration 1290 1298	crónicas
#46	AnnotatorNotes T62	C0205191; chronic; Temporal Concept
T63	LIVB 1317 1324	Sujetos
#47	AnnotatorNotes T63	C0681850; Study Subject; Group
T64	Date 1349 1365	en la actualidad
T65	Date 1368 1380	en el pasado
T66	PHYS 1417 1425	curación
#48	AnnotatorNotes T66	C2004454; Recovery - healing process; Organism Function
T72	LIVB 1247 1258	bacterianas
#49	AnnotatorNotes T72	C0004611; Bacteria; Bacterium
T49	Neg_cue 1382 1387	salvo
A1	Assertion T12 Negated
A2	Assertion T26 Speculated
A3	Population_data T43 Age
A4	Assertion T13 Negated
A5	Status T12 History_of
A6	Status T13 History_of
A7	Status T28 History_of
A8	Status T66 History_of
A9	Assertion T66 Negated
A10	Status T37 History_of
A12	Status T32 History_of
A14	Status T29 History_of
#50	AnnotatorNotes T23	C0007874; Cervix Uteri; Body Part, Organ, or Organ Component | C1278987; Entire cervix uteri; Body Part, Organ, or Organ Component
#51	AnnotatorNotes T4	C1706097; Trial Phase 3B; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#52	AnnotatorNotes T25	C4505301; Anti-Citrullinated Protein Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor
#53	AnnotatorNotes T41	C0332185; Recent; Temporal Concept
#54	AnnotatorNotes T42	C1522438; Subcutaneous Route of Drug Administration; Functional Concept
#55	AnnotatorNotes T58	C0332185; Recent; Temporal Concept
#56	AnnotatorNotes T64	C0521116; Current (present time); Temporal Concept 
#57	AnnotatorNotes T65	C1444637; In the past; Temporal Concept
A11	Assertion T32 Negated
A13	Assertion T37 Negated
T50	Neg_cue 1439 1441	no
T67	Quantifier_or_Qualifier 1442 1453	metastásico
A15	Assertion T67 Negated
#58	AnnotatorNotes T67	C1522484; metastatic qualifier; Functional Concept | C0036525; Metastatic to; Functional Concept
R1	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T67	
R2	Negation Arg1:T50 Arg2:T67	
R3	Experiences Arg1:T40 Arg2:T1	
R4	Experiences Arg1:T40 Arg2:T3	
R5	Overlap Arg1:T2 Arg2:T41	
R6	Overlap Arg1:T3 Arg2:T41	
T68	Observation 46 52	Efecto
#59	AnnotatorNotes T68	C1518681; Outcome of Therapy; Finding (?)
R7	Causes Arg1:T1 Arg2:T68	
R8	Experiences Arg1:T40 Arg2:T68	
R9	Has_Route_or_Mode Arg1:T6 Arg2:T42	
R10	Combined_with Arg1:T6 Arg2:T7	
R11	Used_for Arg1:T8 Arg2:T9	
R12	Experiences Arg1:T43 Arg2:T6	
R13	Experiences Arg1:T43 Arg2:T8	
R14	Experiences Arg1:T43 Arg2:T11	
R15	Negation Arg1:T44 Arg2:T12	
R16	Experiences Arg1:T43 Arg2:T12	
R17	Negation Arg1:T44 Arg2:T13	
R18	Used_for Arg1:T13 Arg2:T12	
T69	Observation 355 371	remisión clínica
#60	AnnotatorNotes T69	C0544452; Disease remission; Finding
R19	Experiences Arg1:T43 Arg2:T69	
R20	Before Arg1:T6 Arg2:T69	
R21	Before Arg1:T8 Arg2:T69	
R22	Before Arg1:T11 Arg2:T69	
T70	Quantifier_or_Qualifier 498 506	temprana
#61	AnnotatorNotes T70	C1279919; Early; Temporal Concept
R23	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T70	
T71	Quantifier_or_Qualifier 407 415	temprana
#62	AnnotatorNotes T71	C1279919; Early; Temporal Concept
R24	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T71	
T73	Quantifier_or_Qualifier 551 559	temprana
#63	AnnotatorNotes T73	C1279919; Early; Temporal Concept
R25	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T73	
R26	Experiences Arg1:T45 Arg2:T15	
R27	Has_Duration_or_Interval Arg1:T17 Arg2:T47	
R28	Has_Duration_or_Interval Arg1:T15 Arg2:T47	
R29	Overlap Arg1:T16 Arg2:T47	
T74	CONC 606 625	criterios ACR/EULAR
R30	Used_for Arg1:T74 Arg2:T16	
R31	Overlap Arg1:T74 Arg2:T46	
T75	Result_or_Value 763 780	> 0,3 mg/dl (LSN)
R32	Has_Result_or_Value Arg1:T34 Arg2:T75	
T76	Result_or_Value 790 799	≥ 28 mm/h
R33	Has_Result_or_Value Arg1:T18 Arg2:T76	
T77	Quantifier_or_Qualifier 822 832	al menos 3
R34	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T77	
R35	Location_of Arg1:T35 Arg2:T19	
R36	Experiences Arg1:T51 Arg2:T19	
R37	Experiences Arg1:T51 Arg2:T20	
R38	Experiences Arg1:T51 Arg2:T21	
T78	Quantifier_or_Qualifier 860 870	al menos 3
R39	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T78	
R40	Overlap Arg1:T19 Arg2:T52	
R41	Overlap Arg1:T20 Arg2:T52	
R42	Overlap Arg1:T21 Arg2:T52	
T79	Result_or_Value 1015 1024	positivos
#64	AnnotatorNotes T79	C1446409; Positive; Finding
R44	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T79	
R45	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T79	
T80	CONC 907 951	Evaluación del recuento de 28 articulaciones
#65	AnnotatorNotes T80	C2732493; Disease activity score 28 joint in rheumatoid arthritis; Intellectual Product (?)
R46	Location_of Arg1:T80 Arg2:T21	
R47	Location_of Arg1:T22 Arg2:T21	
T81	PROC 958 967	selección
#66	AnnotatorNotes T81	C0242802; Patient Selection; Research Activity
R49	Overlap Arg1:T21 Arg2:T81	
R48	Overlap Arg1:T19 Arg2:T81	
R50	Overlap Arg1:T20 Arg2:T81	
T82	CONC 1090 1094	SDAI
#67	AnnotatorNotes T82	C3869582; Simplified disease activity index; Intellectual Product
T83	Result_or_Value 1095 1099	> 11
R51	Has_Result_or_Value Arg1:T82 Arg2:T83	
R52	Experiences Arg1:T55 Arg2:T26	
R53	Speculation Arg1:T56 Arg2:T26	
R54	Overlap Arg1:T27 Arg2:T58	
R55	Experiences Arg1:T57 Arg2:T27	
R56	Causes Arg1:T72 Arg2:T28	
R57	Causes Arg1:T61 Arg2:T28	
R58	Causes Arg1:T60 Arg2:T28	
R59	Experiences Arg1:T59 Arg2:T28	
R60	Has_Duration_or_Interval Arg1:T28 Arg2:T62	
T84	Observation 1301 1312	recurrentes
#68	AnnotatorNotes T84	C0679254; Disease recurrence; Finding
R61	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T84	
R63	Overlap Arg1:T29 Arg2:T64	
R64	Overlap Arg1:T29 Arg2:T65	
R65	Experiences Arg1:T63 Arg2:T29	
R66	Experiences Arg1:T63 Arg2:T66	
R67	Negation Arg1:T49 Arg2:T66	
R68	Negation Arg1:T49 Arg2:T37	
R69	Negation Arg1:T49 Arg2:T32	
R70	Before Arg1:T32 Arg2:T66	
R71	Location_of Arg1:T23 Arg2:T32	
R72	Location_of Arg1:T30 Arg2:T37	
R73	Location_of Arg1:T31 Arg2:T37	
R74	Before Arg1:T37 Arg2:T66	
R75	Experiences Arg1:T63 Arg2:T37	
R76	Experiences Arg1:T63 Arg2:T32	
T85	Result_or_Value 1542 1553	< 40 ml/min
R78	Has_Result_or_Value Arg1:T33 Arg2:T85	
R79	Experiences Arg1:T45 Arg2:T17	
R43	Location_of Arg1:T36 Arg2:T20	
A16	Experiencer T40 Patient
A17	Experiencer T43 Patient
A18	Experiencer T45 Patient
A19	Experiencer T48 Patient
A20	Experiencer T51 Patient
A21	Experiencer T53 Patient
A22	Experiencer T54 Patient
A23	Experiencer T55 Patient
A24	Experiencer T57 Patient
A25	Experiencer T59 Patient
A26	Experiencer T63 Patient
